Skip to content
Screener
Utah Medical Products logo

Utah Medical Products

UTMD

Utah Medical Products Inc develops, manufactures, and markets specialized medical devices designed for critical care, surgical, and biopharmaceutical applications.

Market cap
$236.58M+22.0%
Revenue$36.1M-7.0%
Net income$10.5M-16.5%
Free cash flow$11.4M-17.0%
EPS (diluted)$3.28-12.5%
Trailing twelve months · change vs. prior year

Earnings

Q2 2026 report

July 23, 2026

Next report

Oct 22, 2026 (In 1 week)

Financials

Q2 2026

Income statement

See full
Revenue$8.5M-14.3%
Gross profit$4.8M-15.0%
Operating income$2.6M-17.1%
Net income$2.7M-11.9%
EPS (diluted)$0.84-10.6%

Balance sheet

See full
Cash & equivalents$87.5M+6.5%
Total debt$195.0K-23.8%
Total equity$122.0M+3.8%
Total assets$124.6M+3.1%

Cash flow

See full
Operating cash flow$1.4M-51.9%
CapEx$134.0K+163%
Free cash flow$1.2M-55.7%

Valuation & ratios

Valuation

See full
Market cap$236.58M+22.0%
Enterprise value$149.24M+35.7%
P/E22.6×+5.9×
P/S6.6×+1.5×

Profitability

See full
Gross margin57.9%+0.6pp
Operating margin28.4%-4.1pp
Net margin29%-3.3pp
FCF margin31.7%-3.8pp

Returns & leverage

See full
Return on equity8.8%-1.6pp
Debt / equity0×0.0×
Current ratio48.6×+6.7×

Segments

By product

See full
Gynecology/Electrosurgery/Urology$4.3M-11.0%
Neonatal$1.9M-8.7%
Blood Pressure Monitoring and Accessories$1.3M-37.4%
Obstetrics$1.1M+4.0%

Competitors

Profile

Utah Medical Products Inc develops, manufactures, and markets specialized medical devices designed for critical care, surgical, and biopharmaceutical applications. The company focuses on high-quality, cost-effective solutions that improve patient safety and clinical outcomes in niche medical fields. Its value proposition centers on integrating engineering disciplines to create differentiated products that reduce the total cost of care and minimize procedural complications.

Competitive position

The company maintains a strong competitive position through established brand recognition and specialized clinical utility in niche markets like neonatal care and permanent contraception. It competes by offering differentiated safety features rather than competing solely on unit price.

GeographiesUnited States, United Kingdom, Ireland, Australia, Canada, France, New Zealand
Customer segmentsHospitals, Specialty Clinics, Biopharmaceutical Manufacturers
Business modelManufacturing, Direct-to-Consumer Sales, B2B, OEM
SuppliersSilicone and plastic resin suppliers, Electronic component manufacturers, Tungsten and titanium suppliers, Sterilization service providers
CustomersHospital Group Purchasing Organizations (GPOs), Medical/Surgical Distributors, Biopharmaceutical manufacturing firms, Independent medical product distributors
Listed1982
Employees190.0
CEOKevin L. Cornwell
FilingsSEC EDGAR

FAQ

What is Utah Medical Products's market cap?
Utah Medical Products (UTMD) has a market capitalization of $236.6M and trades on NASDAQ.
What is Utah Medical Products's revenue and profitability?
Utah Medical Products generated $36.1M in trailing twelve-month revenue with net income of $10.5M, representing a net margin of 29.0%. Gross margin stands at 57.9%, with free cash flow of $11.4M. The latest reported period is Q2 2026.
Who are Utah Medical Products's competitors?
Utah Medical Products's key competitors include CooperSurgical Inc., Teleflex Incorporated, C.R. Bard, Inc., and others. These companies compete in similar markets and product categories.
Who does Utah Medical Products partner with?
Utah Medical Products's notable partners include CooperSurgical Inc., Lubrizol Advanced Materials, Inc..
What subsidiaries does Utah Medical Products have?
Utah Medical Products's subsidiaries include Utah Medical Products Ltd, Femcare Holdings Ltd, Columbia Medical, Inc., and others.
Where is Utah Medical Products headquartered?
Utah Medical Products is headquartered in United States of America and employs approximately 190 people. It has been publicly traded since 1982.